GHK-CU 50MG – Copper Peptide Research Material

GHK-CU 50MG is a research-use-only material containing GHK-Cu, also known as glycyl-L-histidyl-L-lysine copper or copper tripeptide. GHK is a naturally occurring three-amino-acid peptide consisting of glycine, histidine, and lysine. It has a strong affinity for copper and can form the GHK-Cu complex, which has been investigated in biochemical and biological research.

GHK-Cu Research

GHK-Cu has been the subject of scientific research for several decades. Researchers have investigated its relationship with extracellular-matrix biology, cellular signaling, copper transport, tissue remodeling, and other biological processes.

Laboratory studies have examined GHK-Cu in cultured human fibroblasts, including research into collagen-related and glycosaminoglycan synthesis. These studies provide useful information for researchers investigating copper-peptide interactions and cellular biology.

Research-Grade Copper Peptide Material

GHK-CU 50MG is presented as a research material for qualified laboratory and analytical applications. It can be used as a research subject in investigations involving peptide chemistry, copper-binding compounds, cellular pathways, and extracellular-matrix research.

Researchers should establish appropriate experimental methods, analytical procedures, storage conditions, and handling protocols according to their laboratory’s requirements and applicable regulations.

Copper Peptide Research

An important characteristic of GHK-Cu is its ability to form a complex with copper(II). Research has examined the chemical behavior and stability of GHK-copper complexes, as well as their biological activity in controlled experimental environments.

This makes GHK-Cu relevant to research involving peptide-metal interactions, copper biology, and related biochemical mechanisms.

GHK-Cu and Cellular Research

GHK-Cu has also been investigated in studies involving extracellular-matrix components and cellular processes. Research using cultured fibroblasts has reported effects on glycosaminoglycan synthesis, while other preclinical studies have examined tissue-remodeling and regenerative mechanisms.

These findings provide areas for continued scientific investigation, but results from laboratory or animal models should not automatically be interpreted as evidence of a particular effect in humans.

Current Research Evidence

The scientific literature on GHK-Cu includes both preclinical and clinical research. A systematic review published in 2026 identified 20 studies examining GHK-Cu in aesthetic medicine, including 18 preclinical studies and 2 randomized controlled trials. The authors noted that the available evidence remains limited and that differences in formulations, study methods, and delivery systems make further standardized research necessary.

For this reason, GHK-CU 50MG should be described accurately as a research material rather than as a proven therapeutic product.

Laboratory Research Use Only

GHK-CU 50MG is intended strictly for research and analytical purposes. It is not intended for human or veterinary use, self-administration, diagnosis, treatment, cure, or prevention of disease.

The product should not be promoted with unsupported medical or therapeutic claims. Researchers should evaluate published evidence and determine appropriate experimental applications independently.

Why Researchers Study GHK-Cu

GHK-Cu remains an interesting research compound because it combines a naturally occurring tripeptide with copper-binding properties. Researchers continue to investigate its chemistry, cellular interactions, extracellular-matrix biology, and other biological mechanisms.

GHK-CU 50MG provides a clearly identified research material for qualified laboratories conducting controlled investigations involving copper peptides, peptide chemistry, and related biological pathways.

Important Research Notice

GHK-CU 50MG is supplied for research purposes only. It is not intended for human or veterinary use and should not be represented as an approved pharmaceutical or therapeutic product.

Researchers should follow appropriate laboratory safety practices, institutional requirements, and applicable regulations when handling this material.